Life-Sciences-Asia.com
The Asian Life Sciences Web Portal

This is a free web portal for the life sciences in Asia... » read more

Full-Life Technologies Acquires Focus-X Tx for up to $245m (2022-11-29)
Acquisition accelerates Full-Life’s transformation into clinical stage radiopharmaceutical company, leveraging its European-focused Radiotechnology and Development Platform Full-Life Technologies, a fully integrated global radiotherapeutics company, today anno...
Sotio Exercises Option for Novel ADC with LegoChem (2022-11-29)
> SOT106 is an antibody-drug conjugate (ADC) targeting an attractive surface antigen expressed on multiple solid tumors. > Preclinical efficacy and tolerability studies of SOT106 show promising results across multiple solid tumor indications and a beneficial the...
V7 Raises $33m Series A to Help Build Robust AI, Faster (2022-11-28)
V7 announces $33m Series A financing co-led by AI-focused Radical Ventures and Temasek, with participation from Air Street Capital, Amadeus Capital, and Partech. > V7, the data engine for AI, announces a $33m Series A funding round, co-led by Radical Ventures an...
Strand Therapeutics Extends Series A with $45m to $97m (2022-11-28)
-- Company’s platform aims to create programmable, long-acting mRNA therapies that offer curative treatments for cancer and beyond -- -- Series A1 round led by new investor FPV Ventures -- Strand Therapeutics, the programmable mRNA company developing curati...
Catalym Closes €50m Series C Led by Brandon Capital & Jeito (2022-11-22)
CatalYm today announced the close of a EUR 50 million (USD 49 million) Series C financing round. The oversubscribed round was co-led by new investors, Brandon Capital and Jeito Capital with participation from existing investors Forbion, Novartis Venture Fund, Vesal...
Uniqure & CSL: FDA Approves Gene Therapy for Hemophilia B (2022-11-22)
> Historic approval provides a new treatment option that reduces the rate of annual bleeds, reduces or eliminates the need for prophylactic therapy, and generates elevated and sustained factor IX levels > uniQure conducted the multi-year clinical development pro...
Fujifilm Invests $188m in Cell Culture Media Plant in RTP (2022-11-22)
> Fujifilm’s fifth media manufacturing site to be operated by FUJIFILM Irvine Scientific > Triples the company’s current capacity for liquid cell culture media production > Creates over 100 new positions, including bioprocessing engineers, manufacturing, produ...
Accession Therapeutics Raises £16.6m Financing Round (2022-11-21)
New Singaporean investor iGlobe Partners backs rapidly developing preclinical pipeline at immunotherapy pioneer’s company Accession Therapeutics, which is developing novel immuno-oncology therapeutics combining high specificity and potency with the ability to ...
Valneva Appoints Dipal Patel as Chief Commercial Officer (2022-11-17)
Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dipal Patel as Chief Commercial Officer (CCO) and Management Board member. With this newly created role, Valneva strengthens its management team with a r...
Kriya Therapeutics Acquires Redpin Therapeutics (2022-11-16)
Kriya Therapeutics, Inc., a fully integrated gene therapy company advancing a broad portfolio of innovative therapeutics, today announced the acquisition of Redpin Therapeutics, Inc., a privately held biotechnology company developing regulatable gene therapies for ...

Life-Sciences-Asia.com is your doorway to the Asian life sciences!

[LSA] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Asian region.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSA] is 100% Made in Germany!

» Start here with the latest News!

Picture Wirtschaftsförderung Sachsen Life Sciences in Saxony 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]